Cosmo First Ltd

- No major new CAPEX plans are expected for the next year, indicating limited immediate need for large-scale fundraising. - Current net debt stands at Rs.1140 crore, considered close to the peak level following recent capacity additions. - Management expects a significant reduction in net debt over the next two years due to lack of major CAPEX. - No specific mention of plans for new debt or equity fundraising was made during the call. - Regarding Zigly, the company plans to scale the business before considering bringing in strategic or financial partners, potentially by 2028 or 2029, but no immediate fundraising is planned. - Overall, current indications suggest no imminent new fundraising through debt or equity.

- The company commissioned a new BOPP line in June 2025 with an annual capacity of approximately 81,000 metric tons, adding around 45% to the company's BOPP capacity. - A window film line under the brand "Sunshield" started operations in May 2025. - Four new lines are to be added this year, with three already added and the fourth expected soon, totaling 10,000 to 12,000 tons of additional capacity. - No major CAPEX planned for the next year after the current year's investments. - The company expects significant ramp-up in revenue and profitability from these recently commissioned assets. - Cost-saving initiatives and efficiency improvements are ongoing, including a Total Quality Management project aimed to increase production capacity by 6-7%. - Specialty chemical business and other verticals like rigid packaging and consumer products are also areas of focus for growth. - Zigly, the pet care venture, is expected to scale up further with possible demerger by 2028-29.

- Company expects sales volume growth due to commissioning of new BOPP line that started operations June 1, adding 45% capacity. - New BOPP line revenue potential is around Rs.750 crore at full capacity, with a ramp-up to 100% utilization expected within 2-3 months. - Specialty product sales, which grew 10% in FY'25, are expected to continue growing in coming years, strengthening the business model. - The company aims to increase specialty mix in new capacity and increase presence with premium brands. - Growth in specialty chemicals and newer verticals like Cosmo consumer (window films, paint protection films, ceramic coatings) and rigid packaging is expected. - Overall topline is expected to increase with volume growth and favorable demand-supply scenario in BOPP industry. - Cost reduction initiatives targeting Rs.40 crore savings per year will support margins along with volume growth. - Zigly business may take time to become profitable but expected to be a value creator.

- The company expects higher volumes due to a 45% increase in BOPP capacity starting June 2025, which will drive top-line growth. - Specialty film sales are projected to grow at around 10% CAGR, strengthening the business model and protecting margins. - A favorable demand-supply scenario in the BOPP industry is expected to continue into FY’26, supporting margins and profitability. - New investments in film lines (BOPP, CPP, window films, paint protection films) are anticipated to ramp up revenue and profitability significantly over the coming years. - Specialty chemicals are already profitable and growing, contributing positively to earnings. - The recently commissioned window film and rigid packaging businesses are expected to break even and generate profits by H2 FY’26 or FY’27. - Zigly (pet care venture) may take time to become profitable but is viewed as a future value creator. - Overall margin and profit improvement is expected from volume growth, cost reductions, and product mix enhancement.

- The company did not provide specific figures on the current or expected order book during the call. - Management mentioned significant queuing up for specialty orders for the new BOPP line within the first two months of operation. - The new BOPP line (81,000 tons capacity) is running at full utilization, expected to reach 100% capacity in 2-3 months. - Specialty film sales from the new line are growing, and additional assets are being added to increase specialty sales. - Overall, volume and top-line are expected to increase in coming quarters due to new capacity ramp-up and specialty mix growth. - No quantified order backlog or pending order data was shared in the transcript.